Hila Karah's most recent trade in DarioHealth Corp was a trade of 20,000 Common Stock done . Disclosure was reported to the exchange on Sept. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DarioHealth Corp | Hila Karah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 20,000 | 30,965 (1%) | 0% | 0 | Common Stock | |
| Indaptus Therapeutics Inc | Hila Karah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | Hila Karah | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Apr 2025 | 500 | 0 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | Hila Karah | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Apr 2025 | 281 | 0 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | Hila Karah | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Apr 2025 | 250 | 0 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | Hila Karah | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Apr 2025 | 250 | 0 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | Hila Karah | Director | 06 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | ||
| DarioHealth Corp | Hila Karah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 70,000 | 219,290 (9%) | 3% | 0 | Common Stock | |
| Indaptus Therapeutics Inc | Hila Karah | Director | 25 May 2023 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | ||
| Indaptus Therapeutics Inc | Hila Karah | Director | 30 Sep 2022 | 13,750 | 13,750 | - | - | Stock Option (right to buy) | ||
| Indaptus Therapeutics Inc | Hila Karah | Director | 04 Aug 2021 | 13,750 | 13,750 | - | - | Stock Option (right to buy) |